Celularity Inc (CELU): Nasdaq/NYSE listing notice — Celularity receives Nasdaq notice for late 10-K filing; must submit compliance plan by June 16, 2025
Celularity Inc
Failed to file 2024 Form 10-K by extension deadline; Nasdaq issued notice of non-compliance on April 16, 2025.
Must submit plan to regain compliance within 60 days (by June 16, 2025) or face potential delisting.
If plan accepted, Celularity has until October 13, 2025 to comply; expects to file 10-K imminently.
No immediate effect on trading under CELU and CELUW.
No guarantee of regaining compliance; delisting risk if plan not accepted.
Celularity Inc received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
late filing
Rules
5250(c)(1)
Exact text from the filing
April 16, 2025, Nasdaq provided formal notice to Celularity that as a result of Celularity’s failure to timely file its 2024 Form 10-K, it no longer complied with the continued listing requirements under the timely filing criteria outlined in Nasdaq Listing Rule 5250(c)(1). Nasdaq’s notice has no immediate effect on the listing of Celularity’s common stock and warrants, which continue to trade on the Nasdaq Capital Market under the symbols “CELU” and “CELUW”, respectively. Celularity is required to submit to Nasdaq a plan to regain compliance within 60 calendar days, or by June 16, 2025, and i
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.